AU7384900A - Extracts of orange peel for prevention and treatment of cancer - Google Patents

Extracts of orange peel for prevention and treatment of cancer Download PDF

Info

Publication number
AU7384900A
AU7384900A AU73849/00A AU7384900A AU7384900A AU 7384900 A AU7384900 A AU 7384900A AU 73849/00 A AU73849/00 A AU 73849/00A AU 7384900 A AU7384900 A AU 7384900A AU 7384900 A AU7384900 A AU 7384900A
Authority
AU
Australia
Prior art keywords
extract
orange peel
methoxyflavone
resveratrol
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73849/00A
Other languages
English (en)
Inventor
Charles Boyd
Kuang Yu Chen
Katalin Csiszar
Geetha Ghai
Chi-Tang Ho
Mou Tuan Huang
Martin Lipkin
Robert T. Rosen
Nitin Telang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of AU7384900A publication Critical patent/AU7384900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU73849/00A 1999-09-21 2000-09-20 Extracts of orange peel for prevention and treatment of cancer Abandoned AU7384900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15501899P 1999-09-21 1999-09-21
US60155018 1999-09-21
PCT/US2000/025733 WO2001021137A1 (en) 1999-09-21 2000-09-20 Extracts of orange peel for prevention and treatment of cancer

Publications (1)

Publication Number Publication Date
AU7384900A true AU7384900A (en) 2001-04-24

Family

ID=22553801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73849/00A Abandoned AU7384900A (en) 1999-09-21 2000-09-20 Extracts of orange peel for prevention and treatment of cancer

Country Status (5)

Country Link
EP (1) EP1214040A4 (ja)
JP (1) JP2003509447A (ja)
AU (1) AU7384900A (ja)
CA (1) CA2383224C (ja)
WO (1) WO2001021137A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020016358A1 (en) * 2000-04-19 2002-02-07 Nof Corporation Cosmetic composition
CA2431196C (en) * 2000-11-15 2012-01-24 Rutgers, The State University Of New Jersey Black tea extract for prevention of disease
US7087790B2 (en) 2003-08-29 2006-08-08 Rutgers, The State University Of New Jersey Benzotropolone derivatives and modulation of inflammatory response
US7351739B2 (en) 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US20070042972A1 (en) * 2005-05-24 2007-02-22 Mckeever Kenneth H Compositions and methods for optimizing exercise recovery
US20070184132A1 (en) * 2006-02-09 2007-08-09 Kgk Synergize Inc Methods of treating canine osteosarcoma
WO2008035208A2 (en) * 2006-05-19 2008-03-27 Kgk Synergize Inc The use of flavonoids for the inhibition of cellular growth
CN100422168C (zh) * 2006-06-15 2008-10-01 中国科学技术大学 橙皮素衍生物及其制备方法
DE102007037772A1 (de) * 2007-08-10 2009-02-12 Csabai, Zsolt, Dr. Ph. Antioxidantenkomplex auf Grape Vital Basis (Citrus- und/oder Traubenkern und/oder Flavonoidbasis)
JP5742050B2 (ja) * 2011-03-01 2015-07-01 国立研究開発法人農業・食品産業技術総合研究機構 Ｎｋ細胞活性化剤、及びｎｋ細胞活性化方法
KR101337059B1 (ko) 2012-05-16 2013-12-06 연세대학교 산학협력단 플라본계 화합물을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
CA3007613A1 (en) * 2015-12-07 2017-06-15 Kyoto University Combination therapy based on pd-1 signal inhibitors
CN115772145A (zh) * 2022-11-29 2023-03-10 三峡大学 一种柑橘属果实提取物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703958B2 (en) * 1995-05-05 1999-04-01 Hauser Inc. High purity carnosic acid from rosemary and sage extracts by PH-controlled precipitation
JPH09176009A (ja) * 1995-12-27 1997-07-08 Inahata Koryo Kk 新規な抗変異原剤及び抗変異原性作用物質
US5830738A (en) * 1996-06-04 1998-11-03 Clemson University Extraction of pigment from plant material
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
JP3571899B2 (ja) * 1997-12-18 2004-09-29 小川香料株式会社 香味劣化抑制剤

Also Published As

Publication number Publication date
WO2001021137A1 (en) 2001-03-29
CA2383224A1 (en) 2001-03-29
CA2383224C (en) 2010-12-07
WO2001021137A8 (en) 2001-07-26
EP1214040A4 (en) 2004-06-23
JP2003509447A (ja) 2003-03-11
EP1214040A1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
ES2224337T3 (es) Procedimiento de preparacion y uso de productos fitoquimicos.
FI119100B (fi) Flavanolignaanien käyttö valmistettaessa lääkkeitä, joilla on antiproliferatiivista vaikutusta kohdussa, munasarjoissa ja rintarauhasessa
Nyamai et al. Medicinally important phytochemicals: an untapped research avenue
Tamayo et al. The chemistry and biological activity of herbs used in Flor‐Essence™ herbal tonic and Essiac
Rios et al. An update review of saffron and its active constituents
CA2383224C (en) Extracts of orange peel for prevention and treatment of cancer
Sovak Grape extract, resveratrol, and its analogs: a review
Islam et al. The potential health benefits of the isoflavone glycoside genistin
Salehi et al. Astragalus species: Insights on its chemical composition toward pharmacological applications
US6391310B1 (en) Method of preparing and using isoflavones for the treatment of neurological symptoms
Tatipamula et al. Phenolic compounds as antidiabetic, anti‐inflammatory, and anticancer agents and improvement of their bioavailability by liposomes
WO2001021165A1 (en) Resveratrol analogs for prevention of disease
Ho et al. Extract from the leaf of nucifera reduced the development of atherosclerosis via inhibition of vascular smooth muscle cell proliferation and migration
González-Gallego et al. Anti-inflammatory and immunomodulatory properties of dietary flavonoids
KR20010071541A (ko) 골다공증 및 폐경기 증후군으로 인한 변화의 예방 및/또는치료를 위한 조성물
Sun et al. The phenolic profiles of Radix Tetrastigma after solid phase extraction (SPE) and their antitumor effects and antioxidant activities in H22 tumor-bearing mice
US7201928B1 (en) Extracts of orange peel for prevention and treatment of cancer
Minamiyama et al. Fermented grain products, production, properties and benefits to health
Chu et al. Antiproliferative effect of sweet orange peel and its bioactive compounds against human hepatoma cells, in vitro and in vivo
González-Gallego et al. Anti-inflammatory, immunomodulatory, and prebiotic properties of dietary flavonoids
US20210315960A1 (en) Compositions of azadirachta indica and methods of treating cancer
Donia et al. Hesperidin: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology
Parnham et al. Mild plant and dietary immunomodulators
Samee et al. Effectiveness of milk thistle on human body against diseases: A comprehensive review
Shehab et al. Preparation and antihepatotoxicity activity of Fagonia indica extract and its solid dispersion formulation.

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE NAME OF THE INVENTOR TO READ GEETHA GHAI

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE APPLICANT'S NAME TO READ: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY